Outlaw Laboratory, LP v. DG in PB, LLC

CourtDistrict Court, S.D. California
DecidedFebruary 18, 2022
Docket3:18-cv-00840
StatusUnknown

This text of Outlaw Laboratory, LP v. DG in PB, LLC (Outlaw Laboratory, LP v. DG in PB, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Outlaw Laboratory, LP v. DG in PB, LLC, (S.D. Cal. 2022).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 IN RE OUTLAW LABORATORY, LP Case No.: 18-cv-840-GPC-BGS LITIGATION. 12 ORDER VACATING TRIAL DATE 13 AND GRANTING PLAINTIFF’S MOTIONS IN LIMINE 14 15 16 \ \ \ 17 \ \ \ 18 \ \ \ 19 \ \ \ 20 \ \ \ 21 \ \ \ 22 \ \ \ 23 \ \ \ 24 \ \ \ 25 26 27 1 I. TRIAL SCHEDULING 2 This case is currently set for a five-day trial beginning on March 8, 2022. Due to 3 the unavoidable congestion of the Court’s trial calendar, and the precedence to which 4 criminal cases are entitled under the Court’s Constitutional obligations, the Court 5 HEREBY VACATES the trial date previously set for this case. A status hearing is set for 6 July 15, 2022 at 1:30 PM. 7 II. PLAINTIFF’S MOTIONS IN LIMINE 8 Pending before the Court are Plaintiffs’1 motions in limine. ECF Nos. 388, 389, 9 390, 391, 392. The Court will address each in turn. 10 A. Motion in Limine No. 1: Amount of Outlaw Settlement (ECF No. 388) 11 Plaintiffs move to exclude the dollar amount of the settlement paid by Outlaw 12 Laboratory, Michael Wear, and Shawn Lynch (“the Outlaw defendants”) as part of the 13 2021 Settlement between the Outlaw defendants and Plaintiffs. ECF No. 388. Under 14 Federal Rule of Evidence (“Rule”) 408(a), a settlement agreement is inadmissible as 15 evidence, unless for a narrow purpose such as proving a witness’ bias or prejudice. Fed. 16 R. Evid. 408(a). To that end, evidence that Michael Wear and Shawn Lynch agreed to 17 testify as part of the settlement agreement is admissible because it goes to the issue of 18 potential bias. However, the settlement amount itself is inadmissible. The Court further 19 concludes that presenting the amount of the settlement to the jury has the potential to 20 confuse and mislead the jury. The Court HEREBY GRANTS Motion in Limine No. 1 21 and excludes the dollar amount of the settlement reached between the Outlaw Defendants 22 and the Stores. 23 24 25 1 Because only the claims of Counterclaimants the Stores (Roma Mikha, Inc., NMRM, 26 Inc., and Skyline Market, Inc.) remain in this action, the Court will refer to them as “Plaintiffs” or “the Stores” for ease of reference. 27 1 B. Motion in Limine No. 2: Criminal Prosecutions of Others (ECF No. 389) 2 Plaintiffs move to exclude “all evidence and argument regarding any criminal 3 prosecutions of importers or other sellers of ‘sex enhancement pills’ of the type that 4 underlie this litigation, and further to exclude evidence and argument regarding the 5 criminal indictment of one of the owners of Outlaw Laboratory, Michael Wear.” ECF No. 6 389 at 2. Specifically, Tauler Smith proposes to call a Mr. Nam Hyun Lee as a witness 7 and admit his guilty plea. See ECF No. 384 (Pretrial Order) at 9, 18. Tauler Smith also 8 lists as exhibits Michael Wear’s indictment for conspiracy to distribute marijuana and an 9 order setting Wear’s bail conditions. Id. at 18 (Exs. X and Y). 10 The Court will exclude evidence of Michael Wear’s indictment as inadmissible 11 impeachment evidence under Rule 609. Fed. R. Evid. 609. Tauler Smith does not propose 12 evidence of Wear’s actual conviction, nor is it clear why distributing marijuana is a crime 13 that would have any bearing on the credibility of Wear’s potential testimony. In addition, 14 the Court finds that evidence of Michael Wear’s indictment for these crimes is of very 15 low probative value, if any, and not relevant to the issues to be decided at trial. 16 The Court will also exclude evidence of Mr. Nam Hyun Lee’s conviction, 17 including his guilty plea and any related documents. Mr. Lee’s situation is substantially 18 different from the context of the instant litigation, in that Mr. Lee was prosecuted by the 19 government for smuggling and importing drugs, rather than sued by a private party for 20 retail sales under RICO and/or the Lanham Act. Thus, his prosecution, conviction, and 21 criminal history have extremely low probative value, if any, and little relevance to the 22 issues central to this case. The Court will also exclude this evidence based on a tendency 23 to confuse the jury, who might think that the government’s success in prosecuting Mr. 24 Lee lends credence to Tauler Smith’s actions as a non-governmental actor. 25 The Court further excludes Tauler Smith’s Exhibit B, “selected criminal 26 prosecutions over related products throughout the country” for the same reasons 27 1 articulated above, related to Mr. Lee. The Court HEREBY GRANTS Motion in Limine 2 No. 2 and excludes evidence regarding the criminal prosecutions of any persons, 3 including Michael Wear and Nam Hyun Lee. 4 C. Motion in Limine No. 3: Denials of Demurrers and Motions to Dismiss 5 in Other Outlaw Cases (ECF No. 390) 6 Plaintiffs seek to exclude Tauler Smith’s Exhibit H, which consists of three orders: 7 (1) the overruling of a demurrer brought by one of the defendants in Outlaw Laboratory 8 v. Lucky Liquor & Mini Mart, et al. (L.A. Sup. Ct. No. SC129302); (2) the overruling of 9 a demurrer in an unspecified California jurisdiction, Case No. BC706471, brought by 10 defendants Overland Mobil Mart and MV Petroleum Corp.; and (3) the denial of a 11 motion to dismiss brought by a defendant in Outlaw Laboratory v. US1 Novelties LLC, et 12 al., No. 18-cv-2065-AT in the Northern District of Georgia. See ECF No. 390 at 2. 13 All three of these cases are decisions on the pleadings stage—i.e., they do not look 14 to the underlying merits of the action, but simply assess whether Outlaw met its burden of 15 pleading at the outset of litigation. As such, they have very little probative value for 16 Tauler Smith’s proposed use: to show that courts ruled in Outlaw’s favor on the merits, 17 thus making it reasonable for them to send the demand letters at issue. The Court finds 18 that these cases have a high likelihood of confusing the jury, which outweighs their 19 minimal probative value, as a jury is unlikely to understand the difference between a 20 motion on the pleadings and a motion on the merits. In addition, any explanation of the 21 difference would waste valuable trial time while producing little benefit for either side. 22 To be clear, the Court is unconvinced that these three cases lend support for Tauler 23 Smith’s contention in the first place. If Tauler Smith were offering cases predating the 24 instant litigation in which a judge had ruled in their favor, even at the pleadings stage, 25 that would be one thing. But each of the three cases offered in Exhibit H was decided 26 after Tauler Smith and Outlaw filed the initial Complaint in this action. Therefore, any 27 1 decision rendered in Tauler Smith and Outlaw’s favor in these three cases could not 2 possibly have lent credence to Tauler Smith’s legal theory and supported the legal 3 soundness of the letters to the Stores before they were sent. Even if such orders could be 4 assumed to a post-hoc vindication of Tauler Smith’s approach—which, since they are not 5 orders on the merits, they cannot be—the Court finds that the cases are excludable 6 evidence due to their low probative value and tendency to confuse the jury and waste 7 time at trial. Given the timing of the decisions, the cases certainly do not lend support to 8 the theory that Tauler Smith’s demands were supported by their own legal victories at the 9 time that the demand letters were sent out in the instant action. The Court therefore 10 GRANTS Motion in Limine No. 3. 11 D. Motion in Limine No. 4: Health Effects Attributed to Subject Pills (ECF 12 No. 391) 13 Plaintiffs seek to exclude evidence or arguments as to adverse health effects 14 allegedly caused by the sexual enhancement pills at issue, including Tauler Smith’s 15 proposed witness, Maxine Fleming. ECF No. 391 at 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Linton
302 P.3d 927 (California Supreme Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Outlaw Laboratory, LP v. DG in PB, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/outlaw-laboratory-lp-v-dg-in-pb-llc-casd-2022.